← All organizations

EXCELYA

For profitWebsite ↗

Also known as: Excelya | EXCELYA Bordeaux | Excelya Germany GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jul 26, 2024

Timeline

2010s

Jun 1, 2014
EXCELYA— Founded

Drugs by trial phase (5 distinct, 4 trials)

Phase 4 (1 own, 0 via acquisition)

tacrolimus

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

amifostine

Other trials (1 own, 0 via acquisition)

totum-854

Indications

Studied for

Acute Pain

Recent trials (4)

NCT07192588CollaboratorPhase 2Jul 26, 2024
NCT05469503CollaboratorN/AJul 15, 2022
NCT04720326CollaboratorPhase 4Dec 23, 2020
NCT04622735CollaboratorPhase 3Nov 30, 2020

Details

Founded: Boulogne, FR Jun 1, 2014
Last known activity: Jul 26, 2024